CELL AND GENE THERAPY INSIGHTS

November 2018 Issue

Volume 4 Issue 11

Cell and Gene Therapy Insights Volume 4 Issue 11
Download PDF

Featuring

Issue Spotlight: Scale-Out and -Up Strategies
Other articles
Webinar

SPOTLIGHT

Scale-Out and -Up Strategies

Expert Insight

Scale-up of lentiviral vectors for gene therapy: advances and challenges

Scale-up of lentiviral vectors for gene therapy: advances and challenges

Alexandra McCarron, Martin Donnelley, David Parsons
16 November 2017
Read

Interview

Approaches and challenges for the manufacture and scale-out of autologous cell therapies

Approaches and challenges for the manufacture and scale-out of autologous cell therapies

Richard Harrison
16 November 2017
Read

articles

Editorial

Critical considerations for allogeneic cell therapy scale up

Critical considerations for allogeneic cell therapy scale up

Sharon Grimster
18 December 2018
Read

Research Article

Methylcellulose as a scaffold in the culture of liver-organoids for the potential of treating acute liver failure

Methylcellulose as a scaffold in the culture of liver-organoids for the potential of treating acute liver failure

A Chandrashekran, V Iansante, A Dhawan et al.
18 December 2018
Read
Scale-up of a perfusion-based dendritic cell generation process

Scale-up of a perfusion-based dendritic cell generation process

A Kozbial, H Weinstein, S K Murthy et al.
18 December 2018
Read

Expert Insight

Back to the future: where are we taking lentiviral vector manufacturing?

Back to the future: where are we taking lentiviral vector manufacturing?

Hanna P Lesch
18 December 2018
Read
Translating cell and gene therapies to the clinic

Translating cell and gene therapies to the clinic

H Dave, D Saunders, N Zhang et al.
18 December 2018
Read
The long road to affordability: a cost of goods analysis for an autologous CAR-T process

The long road to affordability: a cost of goods analysis for an autologous CAR-T process

Katy Spink, Andrew Steinsapir
18 December 2018
Read
Management of ‘out of specification’ commercial autologous CAR-T cell products

Management of ‘out of specification’ commercial autologous CAR-T cell products

Alexey Bersenev, Sven Kili
17 December 2018
Read

Innovator Insight

Commercial Lessons for Clinical Success

Commercial Lessons for Clinical Success

Simon Ellison, Heidi Hagen, Christophe Suchet
19 December 2018
Read

Interview

Biopharma scale-up lessons to learn for cell & gene therapy

Biopharma scale-up lessons to learn for cell & gene therapy

Nik Willoughby
8 January 2019
Read
Towards commercial allogeneic cell therapy manufacturing

Towards commercial allogeneic cell therapy manufacturing

Maria Del Pilar Redondo
18 December 2018
Read
Autologous T cell immunotherapy scale out manufacturing models – the biotech perspective

Autologous T cell immunotherapy scale out manufacturing models – the biotech perspective

Nina Kotsopoulou
18 December 2018
Read

Webinars